SCHEMBL6663166

SCHEMBL6663166

CN(CCC=Cc1ccc(C(N)=O)cn1)C(=O)OC(C)(C)C

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 1/20 0.46
KDM4E B2RXH2 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
NNMT P40261 4/20 0.37
SMN1; SMN2 Q16637 1/20 0.35
GBA1 P04062 1/20 0.34
PDK2 Q15119 1/20 0.33
NPC1 O15118 1/20 0.33
RAB9A P51151 1/20 0.33
AURKA O14965 1/20 0.33
RPS6KB1 P23443 1/20 0.33
OPRM1 P35372 1/20 0.32
OPRD1 P41143 1/20 0.32
OPRK1 P41145 1/20 0.32
METAP2 P50579 1/20 0.32
PARP10 Q53GL7 1/20 0.31
FPR3 P25089 1/20 0.31
FPR2 P25090 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6664110 0.80 FPR3 (0.37) AAK1KDM4EPDK2FPR3FPR2
SCHEMBL6658560 0.80 AAK1 (0.33) AAK1GBA1PDK2METAP2
SCHEMBL6663163 0.79 RAF1 (0.46) AAK1GBA1PDK2
SCHEMBL7099269 0.72 TBXAS1 (0.49) KDM4EL3MBTL1NPC1RAB9A
SCHEMBL7099273 0.72 TBXAS1 (0.49) KDM4EL3MBTL1NPC1RAB9A
SCHEMBL3697124 0.72 OPRM1 (0.55) AAK1NNMTOPRM1OPRD1OPRK1
SCHEMBL6660066 0.71 KDM4E (0.50) KDM4EL3MBTL1NNMTSMN1; SMN2
SCHEMBL31371000 0.68 PDK2 (0.47) AAK1KDM4EGBA1PDK2
SCHEMBL14829450 0.68 AOC3 (0.45) AAK1SMN1; SMN2PARP10
SCHEMBL8429241 0.68 AAK1 (0.38) AAK1KDM4EL3MBTL1NNMTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0973743-B1 PHARMACEUTICAL COMPOSITIONS INCORPORATING ARYL SUBSTITUTED OLEFINIC AMINE COMPOUNDS TARGACEPT INC (US) 2004-08-25 EP disclosed
US-6531606-B1 Nicotinic compound: N-methyl-4-(3-(5-phenylpyridin)yl)-3-buten-1-amine; capable of affecting nicotinic chlorinergic receptors TARGACEPT, INC. 2003-03-11 US disclosed
US-6274606-B1 ADMINISTERING COMPOUNDS SUCH AS (E)-N-METHYL-4-(3-(5-ISO PROPOXYPYRIDIN)YL)-3-BUTEN-1-AMINE TO TREAT PARKINSON'S DISEASE, TOURETTE'S SYNDROME, ATTENTION DEFICIT DISORDER, SCHIZOPHRENIA, AND ALZHEIMER'S DISEASE TARGACEPT, INC. 2001-08-14 US disclosed